Successful Management of Severe Hypercalcemia with Zoledronic Acid: A Report of Two Pediatric Cases
Fatih Kilci1, Jeremy Huw Jones2, Filiz Mine Çizmecioğlu-Jones11Kocaeli University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, Kocaeli, Turkey2Kocaeli University, Department of Academic Writing, Kocaeli, Turkey
Severe hypercalcemia associated with vitamin D intoxication or malignancy in children is a rare and life-threatening condition. There is little published experience with Zoledronic acid (ZA) in the treatment of pediatric severe hypercalcemia. Here, we present two pediatric cases of severe hypercalcemia, one due to vitamin D intoxication and the second to malignancy, in which ZA was used as the first-line bisphosphonate in the treatment. While both cases responded well to a single dose of ZA, the second case experienced hypocalcemia requiring calcium treatment after ZA infusion. Our report shows that ZA may be an effective option in the treatment of severe pediatric hypercalcemia, although patients should be followed closely after infusion due to the risk of hypocalcemia. We provide additional published evidence for the effectiveness of ZA in correcting severe pediatric hypercalcemia and hope this will encourage future studies with larger numbers of patients.
Keywords: Hypercalcemia of malignancy, hypocalcemia, pamidronate, vitamin D intoxication, zoledronic acidManuscript Language: English
